+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

2024 Global Forecast for Psychotherapeutic Agents, Antidepressants (2025-2030 Outlook) - Manufacturing & Markets Report - Product Thumbnail Image

2024 Global Forecast for Psychotherapeutic Agents, Antidepressants (2025-2030 Outlook) - Manufacturing & Markets Report

  • Report
  • March 2024
  • 132 Pages
  • Global
From
2024 Global Forecast for Antipsychotic Drugs (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Thumbnail Image

2024 Global Forecast for Antipsychotic Drugs (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • December 2023
  • 132 Pages
  • Global
From
Depression Treatment Drugs Markets in China - Product Thumbnail Image

Depression Treatment Drugs Markets in China

  • Report
  • November 2023
  • 211 Pages
  • China
From
2023 Global Forecast for Niacin (Vitamin B3) Market (2024-2029 Outlook) - High Tech & Emerging Markets Report - Product Thumbnail Image

2023 Global Forecast for Niacin (Vitamin B3) Market (2024-2029 Outlook) - High Tech & Emerging Markets Report

  • Report
  • June 2023
  • 132 Pages
  • Global
From
ADHD Medication Manufacturing in the US - Industry Market Research Report - Product Thumbnail Image

ADHD Medication Manufacturing in the US - Industry Market Research Report

  • Report
  • August 2022
  • 44 Pages
  • United States
From
2022-2026 Tricyclic Antidepressants Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2022-2026 Tricyclic Antidepressants Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2022
  • Japan, United States, ... Japan, United States, Europe
From
How Selegiline ((-)-Deprenyl) Slows Brain Aging - Product Thumbnail Image

How Selegiline ((-)-Deprenyl) Slows Brain Aging

  • Book
  • January 2012
Psychedelic Drugs Market By Drug Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Psychedelic Drugs Market By Drug Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • October 2023
  • 230 Pages
  • Global
From
Olanzapine Market By Application, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Olanzapine Market By Application, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 229 Pages
  • Global
From
Schizophrenia Drugs Market By Therapeutic Class, By Treatment, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Drugs Market By Therapeutic Class, By Treatment, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • July 2022
  • 220 Pages
  • Global
From
Antidepressant Drugs Market by Product, Depressive Disorder: Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

Antidepressant Drugs Market by Product, Depressive Disorder: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • February 2022
  • 215 Pages
  • Global
From
Antipsychotic Drugs Market by Therapeutic Class, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

Antipsychotic Drugs Market by Therapeutic Class, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • September 2021
  • 187 Pages
  • Global
From
Behavioral Health Market By Disorder, By Service, By Age Group: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Behavioral Health Market By Disorder, By Service, By Age Group: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • February 2024
  • 283 Pages
  • Global
From
The Maudsley Deprescribing Guidelines. Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. Edition No. 1. The Maudsley Prescribing Guidelines Series - Product Thumbnail Image

The Maudsley Deprescribing Guidelines. Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. Edition No. 1. The Maudsley Prescribing Guidelines Series

  • Book
  • February 2024
  • 592 Pages
Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation - Product Thumbnail Image

Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation

  • Book
  • December 2024
Treatment-Resistant Depression Part B. Progress in Brain Research Volume 281 - Product Thumbnail Image

Treatment-Resistant Depression Part B. Progress in Brain Research Volume 281

  • Book
  • September 2023
Treatment-Resistant Depression. Progress in Brain Research Volume 278 - Product Thumbnail Image

Treatment-Resistant Depression. Progress in Brain Research Volume 278

  • Book
  • June 2023
Managing Treatment-Resistant Depression. Road to Novel Therapeutics - Product Thumbnail Image

Managing Treatment-Resistant Depression. Road to Novel Therapeutics

  • Book
  • April 2022
Ketamine for Treatment-Resistant Depression. Neurobiology and Applications - Product Thumbnail Image

Ketamine for Treatment-Resistant Depression. Neurobiology and Applications

  • Book
  • September 2020
Rapid Acting Antidepressants. Advances in Pharmacology Volume 89 - Product Thumbnail Image

Rapid Acting Antidepressants. Advances in Pharmacology Volume 89

  • Book
  • June 2020
  • 402 Pages
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more